# Kyverna Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:28a38147-6f13-4487-be1a-077a9edb268c | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/kyverna-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:52:42.214674+00:00 | | Last reviewed | 2026-10-16T13:52:42.214674+00:00 | ## Identity - Legal name: Kyverna Therapeutics, Inc. - Display name: Kyverna Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T02:57:52.685211+00:00 | | Completeness | 0.409 | | Record Quality | 0.844 | | Directors | 8 | | Committees | 5 | | Governance events | 17 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Andrew Miller, Ph.D.: Director. Status: current. Independent: true. Since: 2026-01-01. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:5 - Beth Seidenberg, M.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:6 - Christi Shaw: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:7 - Fred E. Cohen, M.D., D.Phil.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:8 - Ian Clark: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:9 - Mert Aktar: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (member). claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:10 - Sravan Emany: Director. Status: current. Independent: true. Since: 2026-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:11 - Warner Biddle: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:12 ## Committees - Audit (audit). Chair: Sravan Emany. Members: Sravan Emany (chair, current); Mert Aktar (member, current). committee_id=alpha:committee:kyverna-therapeutics-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Sravan Emany (member, current). committee_id=alpha:committee:kyverna-therapeutics-inc:audit-chair-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Ian Clark (member, current). committee_id=alpha:committee:kyverna-therapeutics-inc:compensation - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Ian Clark (member, current). committee_id=alpha:committee:kyverna-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Ian Clark. Members: Ian Clark (chair, current); Sravan Emany (member, current). committee_id=alpha:committee:kyverna-therapeutics-inc:nominating-and-governance ## Executive leadership - Marc Grasso, M.D.: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:13 - Mayo Pujols: Chief Technology Officer [CTO]. Status: current. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:14 - Naji H. Gehchan, M.D.: Chief Medical and Development Officer. Status: current. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:15 - Warner Biddle: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:16 ## Governance events - CFO_CHANGED: Marc Grasso, M.D. executive of Kyverna Therapeutics, Inc., effective 2026-04-13. Effective: 2026-04-13. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1yj5ibhismfe3 - EXECUTIVE_APPOINTED: Mayo Pujols executive of Kyverna Therapeutics, Inc., effective 2026-04-13. Effective: 2026-04-13. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:epauku15wwrfk - EXECUTIVE_APPOINTED: Naji H. Gehchan, M.D. executive of Kyverna Therapeutics, Inc., effective 2026-04-13. Effective: 2026-04-13. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:ma89fh1nc7uqn - CEO_CHANGED: Warner Biddle executive of Kyverna Therapeutics, Inc., effective 2026-04-13. Effective: 2026-04-13. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1fee6jr10docur - DIRECTOR_APPOINTED: Andrew Miller, Ph.D. seat on Kyverna Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1pa8cbaixe5xm - DIRECTOR_APPOINTED: Sravan Emany seat on Kyverna Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1ik35m7tyd59j - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of Kyverna Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1v3x3253iyn3f - COMMITTEE_MEMBER_ADDED: Sravan Emany member of Audit · Chair; Nominating and Governance, effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:ra3m5zpj7gmb - DIRECTOR_APPOINTED: Christi Shaw seat on Kyverna Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:k6df021ut0hyi - DIRECTOR_APPOINTED: Mert Aktar seat on Kyverna Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1pzg5gy1hzbvlk - DIRECTOR_APPOINTED: Warner Biddle seat on Kyverna Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1ybgeve69995a - COMMITTEE_MEMBER_ADDED: Mert Aktar member of Audit, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:14w6tq1gakq8o - DIRECTOR_APPOINTED: Ian Clark seat on Kyverna Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1ll3trt1g9i7i9 - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Kyverna Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:10w104xd8cvnt - COMMITTEE_MEMBER_ADDED: Ian Clark member of Compensation; Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:11kumky17o1itc - DIRECTOR_APPOINTED: Beth Seidenberg, M.D. seat on Kyverna Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:x89nl684bk2w - DIRECTOR_APPOINTED: Fred E. Cohen, M.D., D.Phil. seat on Kyverna Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T13:52:42.214674+00:00. event_id=alpha:event:transition:1vdrh6cgacse6 ## Scoped resources - `alpha://company/kyverna-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record - `alpha://company/kyverna-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=identity - `alpha://company/kyverna-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/kyverna-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=board - `alpha://company/kyverna-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=committees - `alpha://company/kyverna-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=leadership - `alpha://company/kyverna-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=ownership - `alpha://company/kyverna-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=financials - `alpha://company/kyverna-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/kyverna-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=compensation - `alpha://company/kyverna-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=governance - `alpha://company/kyverna-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/kyverna-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=audit - `alpha://company/kyverna-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=legal - `alpha://company/kyverna-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=risk - `alpha://company/kyverna-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=cyber - `alpha://company/kyverna-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/kyverna-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=agents - `alpha://company/kyverna-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/kyverna-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=events - `alpha://company/kyverna-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=relationships - `alpha://company/kyverna-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=assessments - `alpha://company/kyverna-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:sravan-emany","name":"Sravan Emany"},"source_id":"board_seats"}` - Claim alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mert-aktar","name":"Mert Aktar"},"source_id":"board_seats"}` - Claim alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:ian-clark","name":"Ian Clark"},"source_id":"board_seats"}` - Claim alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:ian-clark","name":"Ian Clark"},"source_id":"board_seats"}` - Claim alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:sravan-emany","name":"Sravan Emany"},"source_id":"board_seats"}` ## Leadership - Andrew Miller, Ph.D.: Director. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:5. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Beth Seidenberg, M.D.: Director. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Christi Shaw: Director. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Fred E. Cohen, M.D., D.Phil.: Director. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Ian Clark: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Mert Aktar: Director, Audit. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Sravan Emany: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:11. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Warner Biddle: Director. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:12. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4. - Marc Grasso, M.D.: Chief Financial Officer. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:13. Valid from: 2026-04-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d947fb0314309262cca4c77a994507350e85ded472b125c4097212d25e25fe22. - Mayo Pujols: Chief Technology Officer. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:14. Valid from: 2026-04-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:42e9767b8a3c179a7bbba9738f68aa87e1ecc86b2734a288d9d4b04b9d14798e. - Naji H. Gehchan, M.D.: Chief Medical and Development Officer. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:15. Valid from: 2026-04-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:913e8f2183c58b02bcfdaf32bb48ed3dc8ec1387e776344ff5bebf01cc01f178. - Warner Biddle: Chief Executive Officer and Director. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:leadership_role:16. Valid from: 2026-04-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d0197d0203f40dcdcfda7f51c69ad6565570c7c1fb59df6e393d8bbe315d403f. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Sravan Emany; Members Sravan Emany (Chair); Mert Aktar. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. - Compensation: Chair not stated; Members Ian Clark. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. - Nominating and Governance: Chair Ian Clark; Members Ian Clark (Chair); Sravan Emany. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Kyverna Therapeutics, Inc.. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:edd9ca1f4294a3eb865a3071e1a690b991dcf4d6bb510bde9984c01a1ace40ba. ## Entity Status - Public listing published. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:edd9ca1f4294a3eb865a3071e1a690b991dcf4d6bb510bde9984c01a1ace40ba. ## Published Fact - US. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:edd9ca1f4294a3eb865a3071e1a690b991dcf4d6bb510bde9984c01a1ace40ba. ## Committee Appointment - Sravan Emany: chair, Audit. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. - Mert Aktar: member, Audit. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. - Ian Clark: member, Compensation. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. - Ian Clark: chair, Nominating and Governance. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. - Sravan Emany: member, Nominating and Governance. Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0. ## Security Listing - KYTX (NASDAQ). Claim: alpha:claim:company:28a38147-6f13-4487-be1a-077a9edb268c:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:edd9ca1f4294a3eb865a3071e1a690b991dcf4d6bb510bde9984c01a1ace40ba. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:edd9ca1f4294a3eb865a3071e1a690b991dcf4d6bb510bde9984c01a1ace40ba: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/kyverna-therapeutics-inc). - alpha:projection-evidence:document:7c1302fa6979657692b724d18ed5f8618fc726a645250c99e3cc259289b5c5c4: [Kyverna Therapeutics, Inc. DEF 14A 2026-04-13](https://www.sec.gov/Archives/edgar/data/1994702/000119312526152835/kytx-20260410.htm). - alpha:projection-evidence:document:d947fb0314309262cca4c77a994507350e85ded472b125c4097212d25e25fe22: [KYTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1994702/000119312526152835/kytx-20260410.htm). - alpha:projection-evidence:document:42e9767b8a3c179a7bbba9738f68aa87e1ecc86b2734a288d9d4b04b9d14798e: [KYTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1994702/000119312526152835/kytx-20260410.htm). - alpha:projection-evidence:document:913e8f2183c58b02bcfdaf32bb48ed3dc8ec1387e776344ff5bebf01cc01f178: [KYTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1994702/000119312526152835/kytx-20260410.htm). - alpha:projection-evidence:document:d0197d0203f40dcdcfda7f51c69ad6565570c7c1fb59df6e393d8bbe315d403f: [KYTX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1994702/000119312526152835/kytx-20260410.htm). - alpha:projection-evidence:cd1dce1093c47fb9b3eda56e82766ed5bdc0c14de57e302f2910736ff04769b0: [Audit](https://www.sec.gov/Archives/edgar/data/1994702/000119312526152835/kytx-20260410.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/kyverna-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/kyverna-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/kyverna-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/kyverna-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T02:57:52.483714+00:00; recorded 2026-10-17T02:57:52.483714+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.